Lilly Strikes $1.3 Billion AI Drug Discovery Deal
Eli Lilly has agreed to a deal worth up to $1.3 billion with Superluminal Medicines to use its AI platform ...
Read moreDetails
© 2025 Newsweek U.S. All rights reserved.
